Together, these findings provide insight into the molecular basis of respiratory failure associated with SMA pathogenesis and identify ZPR1 and HoxA5 as potential targets that lay a foundation for developing therapeutic strategies to treat respiratory distress in SMA. This evidence concerns the gene ZPR1 and respiratory failure.